文献速递主动脉疾病

腹主动脉瘤择期EVAR与开放修复分期生存荟萃分析

Meta-analysis of phase-specific survival after elective endovascular versus surgical repair of abdominal aortic aneurysm from randomized controlled trials and propensity score-matched studies.
PubMed 文献 · J Vasc Surg · 2020-04-21

该荟萃分析纳入4项随机对照试验和7项倾向评分匹配研究,共106,243例肾下腹主动脉瘤患者,比较EVAR与开放修复的分期生存。结果显示EVAR围手术期死亡率显著更低,但中期(2-6年)死亡率显著更高,早期、长期及极长期无显著差异。

要点

  • EVAR围手术期死亡率显著低于开放修复(RR 0.39)。
  • 中期(2-6年)EVAR死亡率显著高于开放修复(HR 1.15)。
  • 长期及极长期两组死亡率无显著差异。

核心结论

  • 对于完整肾下腹主动脉瘤,EVAR围手术期死亡率低于开放修复,但中期死亡率高于开放修复。
  • EVAR在早期无优势,中期劣势在长期和极长期消失。

研究设计与样本

  • 纳入随机对照试验和倾向评分匹配研究,要求报告EVAR vs 开放修复术后≥2年全因死亡率。
  • 共纳入4项随机对照试验和7项倾向评分匹配研究,总计106,243例腹主动脉瘤患者(EVAR n=53,123,开放修复 n=53,120)。
  • 采用随机效应模型分别合并围手术期风险比和分期风险比,并进行敏感性分析和漏斗图不对称检验。

临床怎么用

  • 临床决策应权衡EVAR围手术期获益与中期生存劣势,尤其对预期寿命处于中期范围的患者。
  • EVAR术后中期需加强随访和并发症管理,以降低中期死亡风险。
  • 长期生存无显著差异,提示EVAR与开放修复的远期疗效相当。

局限性

  • 纳入研究数量有限(4项RCT和7项倾向评分匹配研究)。
  • 分期生存分析基于生存曲线提取,可能存在信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) significantly decreases perioperative mortality compared with open surgical repair (OSR), we have not concluded superiority between EVAR and OSR beyond the perioperative period. The aim of this study was to compare phase-specific survival after EVAR vs OSR. METHODS: The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Embase and MEDLINE were searched up to November 2019 to identify randomized controlled trials and propensity score-matched studies that investigated ≥2-year all-cause mortality (primary outcome) after EVAR vs OSR for intact infrarenal AAA. For each study, the hazard ratio (HR) with 95% confidence interval (CI) of mortality for EVAR vs OSR was calculated using survival curves for the following specific phases: early term (0-2 years after repair), midterm (2-6 years after repair), long term (6-10 years after repair), and very long term (≥10 years after repair). The risk ratio (RR) in the perioperative (in-hospital or 30-day) period was also extracted. Phase-specific HRs or RRs were separately pooled using the random effects model. Sensitivity analyses were performed by removing one study at a time to confirm that our findings were not derived from any single study. Funnel plot asymmetry was also examined using the linear regression test. RESULTS: Our search identified four randomized controlled trials and seven propensity score-matched studies enrolling a total of 106,243 AAA patients assigned to EVAR (n = 53,123) or OSR (n = 53,120). The mortality after EVAR compared with OSR was significantly lower in the perioperative period (RR, 0.39; 95% CI, 0.29-0.51; P < .00001) and similar in the early-term period (HR, 0.93; 95% CI, 0.84-1.03; P = .16). Notably, significantly higher mortality was observed in the EVAR group compared with the OSR group in the midterm period (HR, 1.15; 95% CI, 1.03-1.29; P = .01). However, similar mortality was observed between the EVAR group and the OSR group in the long-term (HR, 1.06; 95% CI, 0.96-1.17; P = .27) and very-long-term (HR, 1.17; 95% CI, 0.93-1.47; P = .19) periods. In sensitivity analyses, the significant benefit of EVAR in the perioperative period and that of OSR in the midterm period were not changed. No funnel plot asymmetry was identified in all analyses. CONCLUSIONS: Compared with OSR, EVAR was associated with lower perioperative mortality and higher mortality in the midterm period for intact infrarenal AAA. The superiority of EVAR was absent in the early-term period, and the inferiority of EVAR in the midterm period disappeared in the long-term and very-long-term periods.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Yokoyama Y, Kuno T, Takagi H, et al. Meta-analysis of phase-specific survival after elective endovascular versus surgical repair of abdominal aortic aneurysm from randomized controlled trials and propensity score-matched studies. J Vasc Surg. 2020. PMID: 32330598. doi:10.1016/j.jvs.2020.03.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。